Literature DB >> 18181732

Clinical indications for probiotics: an overview.

B R Goldin1, S L Gorbach.   

Abstract

Probiotic bacteria are used to treat or prevent a broad range of human diseases, conditions, and syndromes. In addition, there are areas of medical use that have been proposed for future probiotic applications. Randomized double-blind studies have provided evidence of probiotic effectiveness for the treatment and prevention of acute diarrhea and antibiotic-induced diarrhea, as well as for the prevention of cow milk-induced food allergy in infants and young children. Research studies have also provided evidence of effectiveness for the prevention of traveler's diarrhea, relapsing Clostridium difficile-induced colitis, and urinary tract infections. There are also studies indicating that probiotics may be useful for prevention of respiratory infections in children, dental caries, irritable bowel syndrome, and inflammatory bowel disease. Areas of future interest for the application of probiotics include colon and bladder cancers, diabetes, and rheumatoid arthritis. The probiotics with the greatest number of proven benefits are Lactobacillus rhamnosus strain GG and Saccharomyces boulardii.

Entities:  

Mesh:

Year:  2008        PMID: 18181732     DOI: 10.1086/523333

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  37 in total

1.  Integrative medicine is integral to providing patient-centered care.

Authors:  Maureen George
Journal:  Ann Allergy Asthma Immunol       Date:  2015-02-03       Impact factor: 6.347

Review 2.  Probiotics - the versatile functional food ingredients.

Authors:  Gareth Gordon Syngai; Ragupathi Gopi; Rupjyoti Bharali; Sudip Dey; G M Alagu Lakshmanan; Giasuddin Ahmed
Journal:  J Food Sci Technol       Date:  2015-11-09       Impact factor: 2.701

3.  Perceptions of medical sciences students towards probiotics.

Authors:  Laleh Payahoo; Zeinab Nikniaz; Reza Mahdavi; Mohamad Asghari Jafar Abadi
Journal:  Health Promot Perspect       Date:  2012-07-01

4.  From probiotics to therapeutics: another step forward?

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

5.  Development of probiotic tablets using microparticles: viability studies and stability studies.

Authors:  J P Sousa e Silva; Sérgio C Sousa; Paulo Costa; Emília Cerdeira; Maria H Amaral; José Sousa Lobo; Ana M Gomes; Maria M Pintado; Dina Rodrigues; Teresa Rocha-Santos; Ana C Freitas
Journal:  AAPS PharmSciTech       Date:  2012-12-12       Impact factor: 3.246

Review 6.  Early life microbial exposures and allergy risks: opportunities for prevention.

Authors:  Harald Renz; Chrysanthi Skevaki
Journal:  Nat Rev Immunol       Date:  2020-09-11       Impact factor: 53.106

7.  New antimicrobial agents for patients with Clostridium difficile infections.

Authors:  John G Bartlett
Journal:  Curr Infect Dis Rep       Date:  2009-01       Impact factor: 3.725

8.  Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations.

Authors:  S A Cohen; M C Woodfield; N Boyle; Z Stednick; M Boeckh; S A Pergam
Journal:  Transpl Infect Dis       Date:  2016-09-21       Impact factor: 2.228

9.  Left-sided brain injury associated with more hospital-acquired infections during inpatient rehabilitation.

Authors:  Pasquale G Frisina; Ann M Kutlik; Anna M Barrett
Journal:  Arch Phys Med Rehabil       Date:  2012-11-01       Impact factor: 3.966

10.  Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial.

Authors:  David R Mandel; Katy Eichas; Judith Holmes
Journal:  BMC Complement Altern Med       Date:  2010-01-12       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.